Nanopharmaceuticals 2020
DOI: 10.1016/b978-0-12-817778-5.00002-6
|View full text |Cite
|
Sign up to set email alerts
|

Role of nanocarriers and their surface modification in targeting delivery of bioactive compounds

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 120 publications
0
6
0
Order By: Relevance
“…The optimal coating technique for all lipid-based nanocarriers that allows for improved selectivity cannot be determined . Additionally, for each new ligand-lipid-based nanocarriers development and to prevent the targeted ligands from becoming inactive, the optimization of functionalization approach must be thoroughly examined . Purification of lipid-based nanocarriers following surface functionalization is a key problem to achieve a reliable characterization of functionalized lipid-based nanocarriers.…”
Section: Current Challenges and Future Perspectivesmentioning
confidence: 99%
See 2 more Smart Citations
“…The optimal coating technique for all lipid-based nanocarriers that allows for improved selectivity cannot be determined . Additionally, for each new ligand-lipid-based nanocarriers development and to prevent the targeted ligands from becoming inactive, the optimization of functionalization approach must be thoroughly examined . Purification of lipid-based nanocarriers following surface functionalization is a key problem to achieve a reliable characterization of functionalized lipid-based nanocarriers.…”
Section: Current Challenges and Future Perspectivesmentioning
confidence: 99%
“…Low concentrations and very short residence time of the drugs at the cellular and target sites are major factors that contribute to the inability to eradicate the disease and the development of multidrug resistance against the therapeutic drugs. 14,15 Nanocarriers can also boost the biodistribution of therapeutics to the target organs and improve pharmacokinetics, which leads to increased efficacy and minimize side effects. 3 Surface-modified lipid-based nanocarriers result in targeted medication delivery because they maintain appropriate therapeutic concentrations at the targeted site for a prolonged time.…”
Section: Surface Modifiers Utilized For Surface Modification Of Lipid...mentioning
confidence: 99%
See 1 more Smart Citation
“…Many bioactive compounds possess limited solubility in water, bioavailability, and reduced stability 17 . Nowadays, this is still a challenge for pharma industry and new drug developments.…”
Section: Introductionmentioning
confidence: 99%
“…[14][15][16] Many bioactive compounds possess limited solubility in water, bioavailability, and reduced stability. 17 Nowadays, this is still a challenge for pharma industry and new drug developments. For example, caffeic acid phenethyl ester (CAPE), also known as phenylethyl caffeate or phenethyl caffeate is a natural bioactive substance which has overabundance of important pharmacological and biological activities such as antioxidant, antiviral, antiallergic, antimicrobial, anti-inflammatory, immunomodulatory, and anticancer effect.…”
Section: Introductionmentioning
confidence: 99%